Novo Nordisk A/S Common Stock (NY:NVO)
36.17
+0.88
(+2.51%)
Streaming Delayed Price
Updated: 10:29 AM EDT, Mar 31, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 4,646,794 |
| Open | 35.41 |
| Bid (Size) | 36.17 (800) |
| Ask (Size) | 36.18 (5,300) |
| Prev. Close | 35.29 |
| Today's Range | 35.32 - 36.20 |
| 52wk Range | 35.12 - 81.44 |
| Shares Outstanding | N/A |
| Dividend Yield | 3.23% |
Top News
More News
Performance
More News
Read More
1 Reason Eli Lilly Stock Is Still a Buy ↗
March 28, 2026
Could Buying Eli Lilly Today Set You Up for Life? ↗
March 26, 2026
What's Happening With Novo Nordisk Stock Today? ↗
March 26, 2026
Surging Oil Prices Spark Market Jitters ↗
March 25, 2026
Should You Buy Eli Lilly Stock Before April 10? ↗
March 22, 2026
Is This Stock a Buy on the Dip? ↗
March 21, 2026
This Hims & Hers Move Could Destroy Competitors ↗
March 21, 2026
Is It Too Late to Buy Eli Lilly? ↗
March 19, 2026
1 Reason I'm Never Selling Novo Nordisk Stock ↗
March 19, 2026
The Best Healthcare Stocks to Buy With $50 Right Now ↗
March 18, 2026
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 36.17
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 03/31/26 10:29 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
